National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Research
 Research by Topic
 Research Resources
  Clinical Research Toolkit
  DAIDS Clinical Research Policies
  DMID Clinical Research Policies
  DMID Services for Researchers
  HIV/AIDS Specimen Repository
  Rabbit Immunology


Services for Researchers

In Vitro Antiviral Screening Program 

Prioritization and Approval Process

Materials for testing are selected and prioritized by relevant program officers from the Division of Microbiology and Infectious Diseases (DMID). Submitted compounds will be evaluated based on criteria such as structural novelty and drug-like characteristics as well as the rationale for submission, program priorities, and budgeted capacities in the antiviral screens requested. Final decisions are communicated to the submitter by the NIAID Project Officer.

 


Contact Info

Christopher Tseng
DMID Program Officer
E-mail: ctseng@niaid.nih.gov




 
Search in Research
 
E-mail Icon E-mail this page
Print Icon Print this page

Contact Info

Christopher Tseng
DMID Program Officer
E-mail: ctseng@niaid.nih.gov